Delivery Order SPE2DB25D2204-SPE2DB25FTGPV

Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $70K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,572.54, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of March 21, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,574.56 and is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medical supplies. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,426.82, is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The award has an ultimate completion date of May 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,997.42 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medication. The $62,005.26 delivery order contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2025. The contract is not set-aside and represents an order under AmerisourceBergen Drug Corp's larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,149.12 delivery order contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 23, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $14,729.86 for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Defense Logistics Agency (DLA) awarded this Firm Fixed Price Delivery Order valued at $76,451.94 for the supply of COSENTYX UNOREADY 300 mg pen 2ml. The contract has an ultimate completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a $17,086.27 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of COSENTYX UNOREADY 300 mg pen, a specialty pharmaceutical product. The award is not set aside and has an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $35,609.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB25D2204
    Indefinite Delivery Contract
  • SPE2DB25D2204-SPE2DB25FTGPV
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $69,520.77 and a completion date of June 9, 2025. The award is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/5/25, 10:02 AM